$100M Hercules loan backs Lexicon (NASDAQ: LXRX) refi and milestones
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Lexicon Pharmaceuticals entered a new loan and security agreement with Hercules Capital providing up to $100 million in term loans maturing in May 2030. An initial $55 million tranche was funded at closing and will be used to repay Lexicon’s existing Oxford Finance loan facility.
The facility carries a floating interest rate equal to the prime rate plus 3.10%, with a floor of 9.85%, and an initial interest-only period of 18 months that can be extended up to 30 months upon achievement of specified clinical, regulatory and financial milestones. The loans are secured by a first lien on all assets and include minimum cash and revenue covenants and other customary restrictions.
In connection with the financing, Lexicon granted Hercules warrants to purchase up to 1,257,860 shares of common stock at $1.59 per share, exercisable for five years, issued in stages alongside the three loan tranches.
Positive
- None.
Negative
- None.
Insights
Lexicon refinances debt and adds flexible, milestone-tied borrowing capacity.
Lexicon has arranged up to $100 million in term loans with Hercules Capital, with $55 million funded immediately to repay its Oxford Finance facility. The structure staggers additional $20 million and $25 million tranches, available only after specified clinical, regulatory and financial milestones.
The facility runs to May 2030, with interest-only payments for at least 18 months, extendable to 30 months upon milestone achievement. Covenants include minimum cash starting June 1, 2027 and revenue tests triggered by later draws, but these can be waived if Lexicon meets defined market-cap or cash thresholds.
Warrants for up to 1,257,860 shares at $1.59 per share modestly offset the “non-dilutive” nature of the debt but are spread across tranches. Overall impact depends on Lexicon’s ability to hit SONATA-HCM and FDA milestones and access later tranches on favorable terms.
8-K Event Classification
5 items: 1.01, 2.03, 3.02, 7.01, 9.01
5 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 3.02
Unregistered Sales of Equity Securities
Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Total loan capacity: $100 million
First tranche funded: $55 million
Second tranche size: $20 million
+5 more
8 metrics
Total loan capacity
$100 million
Hercules term loan facility maturing May 2030
First tranche funded
$55 million
Initial draw at closing to repay Oxford Finance loan
Second tranche size
$20 million
Available after Tranche 2 milestones, by June 15, 2028
Third tranche size
$25 million
Available at Lexicon’s option with Hercules consent
Interest rate
Prime + 3.10%, floor 9.85%
Floating rate on Hercules term loans
Warrant exercise price
$1.59 per share
Common stock warrants issued to Hercules
Initial warrant shares
691,823 shares
Warrants issued with first $55M tranche
Final payment fee
6.25% of funded amount
Due at prepayment or maturity under term loans
Key Terms
loan and security agreement, interest-only period, minimum cash covenant, warrants, +2 more
6 terms
loan and security agreement financial
"entered into a loan and security agreement with Hercules Capital"
A loan and security agreement is a legal contract that sets out the amount, repayment schedule, interest and the rules a borrower must follow, and it names specific assets a lender can claim if the borrower fails to pay. Think of it like a mortgage or car loan where the lender holds a claim on collateral until the debt is repaid. Investors care because it determines a company’s repayment priorities, borrowing costs, operational limits and how easily creditors can seize assets in distress, all of which affect equity value and credit risk.
interest-only period financial
"Monthly interest-only payments are due during an initial 18-month period"
A period during a loan when the borrower pays only the interest charges and none of the original principal, so monthly payments are lower but the loan balance does not shrink. For investors, this affects cash flow and risk: borrowers may have higher near-term liquidity but face larger payments or refinancing later, which can influence a company’s ability to pay dividends, meet obligations, or require new financing — similar to paying rent on borrowed money before starting to pay it down.
minimum cash covenant financial
"Financial covenants include (a) a minimum cash covenant beginning on June 1, 2027"
A minimum cash covenant is a loan agreement clause that requires a company to keep at least a specified amount of cash or liquid assets on hand, like a bank requiring you to maintain a minimum balance. It matters to investors because it limits how management can spend or return cash, reduces the risk of surprise default by ensuring a short-term safety buffer, and can signal lender concern about the company’s liquidity.
warrants financial
"Lexicon agreed to grant Hercules warrants to purchase a number of shares"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
non-dilutive capital financial
"Access to this non-dilutive capital provides Lexicon with greater financial flexibility"
Funding that does not require a company to issue new shares or reduce existing owners’ percentage of ownership, such as grants, certain loans, licensing deals, or customer prepayments. It matters to investors because it preserves each shareholder’s stake and per-share value—like getting a loan or a gift instead of selling part of the company—while still carrying obligations (repayment, milestones, or restrictions) that can affect future cash flow and growth.
first lien security interest financial
"secured by a first lien security interest in all of the assets of Lexicon"
A first lien security interest is a lender's legally enforceable right to specific assets of a borrower that gives that lender the top-priority claim if the borrower defaults. For investors, that priority matters because it generally increases the chance of recovering funds, lowers credit risk and often translates into lower borrowing costs compared with lower-ranked claims—like being first in line at a repayment counter rather than behind other creditors.
FAQ
What is the size and structure of Lexicon (LXRX) loan facility with Hercules Capital?
Lexicon arranged a loan facility of up to $100 million with Hercules Capital, split into three tranches: an initial $55 million funded at closing, a $20 million tranche, and a $25 million tranche, each maturing in May 2030 and tied to specified conditions.
What interest rate applies to Lexicon (LXRX) new Hercules term loans?
The Hercules term loans bear a floating interest rate equal to the prime rate plus 3.10%, with a minimum rate of 9.85%. If an event of default occurs and continues, additional default interest applies, and Hercules may declare all outstanding amounts immediately due and payable under the agreement’s terms.
What milestones affect Lexicon (LXRX) access to additional loan tranches and interest-only extensions?
Extension of the interest-only period and access to the second and third tranches depend on milestones including SONATA-HCM Phase 3 meeting its primary endpoint, FDA approval of sotagliflozin for HCM, and specified financial metrics. These milestones also influence covenant timing and potential waivers tied to cash and market capitalization levels.
How will Lexicon (LXRX) use the initial $55 million from the Hercules facility?
The initial $55 million tranche, funded at closing, will be used to repay Lexicon’s existing loan facility with Oxford Finance. This refinancing consolidates Lexicon’s secured debt under Hercules while extending the maturity date and establishing a new interest-only period and updated covenant framework.
What warrant rights did Hercules receive in Lexicon (LXRX) financing?
Lexicon granted Hercules warrants to buy shares equal to 2% of term loans funded at a $1.59 exercise price. That includes 691,823 shares issued with the first tranche and up to 251,572 and 314,465 additional shares tied to the second and third tranches, all exercisable for five years with cashless exercise allowed.
What key financial covenants are included in Lexicon (LXRX) Hercules loan agreement?
Financial covenants include a minimum cash covenant beginning on June 1, 2027, potentially extended to January 1, 2028, and a minimum revenue covenant linked to net product sales after drawing later tranches. These requirements can be waived when Lexicon meets specified cash and market capitalization thresholds under the agreement.